Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionnucleoside-triphosphatase regulator activity

CCDC88C ARHGEF28 GOPC TRIO MYO9A RAPGEF3 RALBP1 NUCB1 LRRK2 OBSCN

7.81e-055078810GO:0060589
GeneOntologyMolecularFunctionGTPase regulator activity

CCDC88C ARHGEF28 GOPC TRIO MYO9A RAPGEF3 RALBP1 NUCB1 LRRK2 OBSCN

7.81e-055078810GO:0030695
GeneOntologyBiologicalProcesspositive regulation of RIG-I signaling pathway

DDX60 PUM2 PUM1

1.21e-0511883GO:1900246
GeneOntologyBiologicalProcesscentrosome localization

AKAP9 SYNE1 CEP83 CCDC141

1.46e-0535884GO:0051642
GeneOntologyBiologicalProcessmicrotubule organizing center localization

AKAP9 SYNE1 CEP83 CCDC141

1.64e-0536884GO:0061842
GeneOntologyBiologicalProcesscell morphogenesis involved in neuron differentiation

ADCY10 WHRN ARHGEF28 TRIO USP9X SYNE1 GLI3 NTRK3 LRRK2 GOLGA6A SLITRK6 CTTN ATL1

1.65e-057488813GO:0048667
GeneOntologyBiologicalProcessneuron projection morphogenesis

ADCY10 ARHGEF28 TRIO MYO9A USP9X SYNE1 GLI3 NTRK3 LRRK2 GOLGA6A SLITRK6 CTTN ATL1

3.42e-058028813GO:0048812
GeneOntologyBiologicalProcesscilium organization

NEDD9 DNHD1 CCDC88C USP9X SYNE1 CFAP221 FBF1 IQCB1 CEP83 CEP164

3.52e-054768810GO:0044782
GeneOntologyBiologicalProcessplasma membrane bounded cell projection morphogenesis

ADCY10 ARHGEF28 TRIO MYO9A USP9X SYNE1 GLI3 NTRK3 LRRK2 GOLGA6A SLITRK6 CTTN ATL1

4.25e-058198813GO:0120039
GeneOntologyBiologicalProcesscell projection morphogenesis

ADCY10 ARHGEF28 TRIO MYO9A USP9X SYNE1 GLI3 NTRK3 LRRK2 GOLGA6A SLITRK6 CTTN ATL1

4.63e-058268813GO:0048858
GeneOntologyBiologicalProcesspositive regulation of sprouting of injured axon

NTRK3 PUM2

5.38e-053882GO:0048687
GeneOntologyBiologicalProcesspositive regulation of cellular component organization

NEDD9 ADCY10 SFTPA2 AKAP9 HDAC4 RAPGEF3 RALBP1 SYNE1 NTRK3 LRRK2 PUM2 SFTPA1 ACTN4 FYCO1 GOLGA6A SLITRK6 CTTN

5.63e-0513668817GO:0051130
GeneOntologyBiologicalProcessGolgi organization

AKAP9 SYNE1 LRRK2 GOLGA6A ATL2 TRIP11

8.33e-05168886GO:0007030
GeneOntologyBiologicalProcessorganelle assembly

ABRAXAS2 DNHD1 USP9X SYNE1 NTRK3 CFAP221 FBF1 IQCB1 LRRK2 CEP83 OBSCN PUM2 GOLGA6A CEP164 WDR62

8.70e-0511388815GO:0070925
GeneOntologyBiologicalProcessaxon development

ADCY10 ARHGEF28 TRIO USP9X GLI3 NTRK3 PUM2 GOLGA6A SLITRK6 CTTN ATL1

8.88e-056428811GO:0061564
GeneOntologyBiologicalProcessregulation of RIG-I signaling pathway

DDX60 PUM2 PUM1

9.44e-0521883GO:0039535
GeneOntologyBiologicalProcessneuron projection development

ADCY10 WHRN ARHGEF28 TRIO MYO9A USP9X SYNE1 GLI3 NTRK3 LRRK2 PUM2 GOLGA6A SLITRK6 CTTN TRIP11 ATL1

9.58e-0512858816GO:0031175
GeneOntologyBiologicalProcesscytosolic ciliogenesis

USP9X IQCB1

1.07e-044882GO:0061824
GeneOntologyBiologicalProcessendoplasmic reticulum tubular network membrane organization

ATL2 ATL1

1.07e-044882GO:1990809
GeneOntologyBiologicalProcessneuron development

ADCY10 WHRN ARHGEF28 TRIO MYO9A USP9X SYNE1 GLI3 NTRK3 LRRK2 PUM2 RORB GOLGA6A SLITRK6 CTTN TRIP11 ATL1

1.31e-0414638817GO:0048666
GeneOntologyBiologicalProcessaxonogenesis

ADCY10 ARHGEF28 TRIO USP9X GLI3 NTRK3 GOLGA6A SLITRK6 CTTN ATL1

1.48e-045668810GO:0007409
GeneOntologyBiologicalProcesscell morphogenesis

ADCY10 WHRN CCDC88C ARHGEF28 TRIO MYO9A USP9X SYNE1 GLI3 NTRK3 LRRK2 GOLGA6A SLITRK6 CTTN ATL1

1.48e-0411948815GO:0000902
GeneOntologyBiologicalProcessregulation of sprouting of injured axon

NTRK3 PUM2

1.78e-045882GO:0048686
GeneOntologyBiologicalProcesscell junction organization

NEDD9 WHRN MYO9A USP9X NTRK3 FBF1 LRRK2 NBEA ACTN4 SLITRK6 ITGA5 CTTN ELFN2

2.40e-049748813GO:0034330
GeneOntologyBiologicalProcesssprouting of injured axon

NTRK3 PUM2

2.67e-046882GO:0048682
GeneOntologyBiologicalProcessRIG-I signaling pathway

DDX60 PUM2 PUM1

2.80e-0430883GO:0039529
GeneOntologyBiologicalProcesssmall GTPase-mediated signal transduction

CCDC88C ARHGEF28 TRIO MYO9A RAPGEF3 RALBP1 NUCB1 LRRK2 OBSCN

4.80e-04538889GO:0007264
GeneOntologyBiologicalProcessplasma membrane bounded cell projection assembly

DNHD1 HDAC4 USP9X SYNE1 CFAP221 FBF1 IQCB1 CEP83 CTTN CEP164

5.64e-046708810GO:0120031
GeneOntologyBiologicalProcessendoplasmic reticulum to Golgi vesicle-mediated transport

GOPC LRRK2 GOLGA6A ATL2 TRIP11

5.98e-04159885GO:0006888
GeneOntologyBiologicalProcesscilium assembly

DNHD1 USP9X SYNE1 CFAP221 FBF1 IQCB1 CEP83 CEP164

6.18e-04444888GO:0060271
GeneOntologyCellularComponentciliary transition fiber

FBF1 CEP83 CEP164

9.06e-0610903GO:0097539
GeneOntologyCellularComponentaxon

ADCY10 WHRN SACS TRPM7 MYO9A RAPGEF3 USP9X NTRK3 LRRK2 EEA1 CTTN PUM1 UNC80 ATL1

2.61e-058919014GO:0030424
GeneOntologyCellularComponentpostsynapse

WHRN AKAP9 GOPC TRIO MYO9A USP9X SYNE1 NTRK3 LRRK2 NBEA ACTN4 EEA1 ITGA5 CTTN ELFN2

2.75e-0510189015GO:0098794
GeneOntologyCellularComponentmicrotubule organizing center

NEDD9 ABRAXAS2 WHRN CCDC88C AKAP9 CEP112 USP9X FBF1 IQCB1 CEP83 CCDC141 CEP164 WDR62 KLHL4

3.67e-059199014GO:0005815
GeneOntologyCellularComponentgrowth cone

ADCY10 WHRN MYO9A RAPGEF3 USP9X LRRK2 CTTN

9.11e-05245907GO:0030426
GeneOntologyCellularComponentsite of polarized growth

ADCY10 WHRN MYO9A RAPGEF3 USP9X LRRK2 CTTN

1.11e-04253907GO:0030427
GeneOntologyCellularComponentcentrosome

ABRAXAS2 CCDC88C AKAP9 CEP112 USP9X FBF1 IQCB1 CEP83 CCDC141 CEP164 WDR62 KLHL4

1.13e-047709012GO:0005813
GeneOntologyCellularComponentendoplasmic reticulum tubular network membrane

ATL2 ATL1

1.82e-045902GO:0098826
GeneOntologyCellularComponentspindle pole

NEDD9 ABRAXAS2 RALBP1 FBF1 GOLGA6A WDR62

2.60e-04205906GO:0000922
GeneOntologyCellularComponentcilium

NEDD9 ADCY10 WHRN DNHD1 AKAP9 USP9X GLI3 CFAP221 FBF1 IQCB1 CEP83 CEP164

4.60e-048989012GO:0005929
GeneOntologyCellularComponentcis-Golgi network

AKAP9 GOLIM4 GOLGA6A TRIP11

4.99e-0485904GO:0005801
GeneOntologyCellularComponentglutamatergic synapse

PRUNE2 AKAP9 TRIO MYO9A NTRK3 LRRK2 NBEA EEA1 ITGA5 CTTN PPM1H

7.58e-048179011GO:0098978
GeneOntologyCellularComponentGolgi stack

AKAP9 NUCB1 GOLIM4 GOLGA6A ATL1

8.67e-04171905GO:0005795
GeneOntologyCellularComponentcentriole

FBF1 IQCB1 CEP83 CEP164 WDR62

8.90e-04172905GO:0005814
GeneOntologyCellularComponentspindle

NEDD9 ABRAXAS2 RALBP1 FBF1 IQCB1 GOLGA6A CTTN WDR62

9.65e-04471908GO:0005819
GeneOntologyCellularComponentmitotic spindle

NEDD9 IQCB1 GOLGA6A CTTN WDR62

1.77e-03201905GO:0072686
GeneOntologyCellularComponentdistal axon

ADCY10 WHRN MYO9A RAPGEF3 USP9X LRRK2 CTTN

2.73e-03435907GO:0150034
GeneOntologyCellularComponentGolgi cisterna

NUCB1 GOLIM4 GOLGA6A ATL1

2.77e-03135904GO:0031985
GeneOntologyCellularComponentpostsynaptic actin cytoskeleton

ACTN4 CTTN

2.99e-0319902GO:0098871
GeneOntologyCellularComponentGolgi apparatus subcompartment

AKAP9 NUCB1 LRRK2 GOLIM4 NBEA GOLGA6A ATL1

3.02e-03443907GO:0098791
GeneOntologyCellularComponentlamellar body

SFTPA2 SFTPA1

3.65e-0321902GO:0042599
GeneOntologyCellularComponentGolgi membrane

MAN2A2 GOPC NUCB1 LRRK2 GOLIM4 GOLGA6A ST8SIA3 TRIP11 ATL1

3.85e-03721909GO:0000139
GeneOntologyCellularComponentZ disc

HDAC4 OBSCN ACTN4 RYR1

4.13e-03151904GO:0030018
GeneOntologyCellularComponentsarcomere

HDAC4 SYNE1 OBSCN ACTN4 RYR1

4.45e-03249905GO:0030017
GeneOntologyCellularComponentSchaffer collateral - CA1 synapse

TRIO MYO9A RALBP1 EEA1

4.53e-03155904GO:0098685
MousePhenoabnormal podocyte adhesion

MYO9A ACTN4

2.76e-052742MP:0011864
MousePhenoabnormal right lung middle lobe morphology

GLI3 ZFPM2

2.76e-052742MP:0009573
MousePhenoabnormal grooming behavior

HDAC4 SYNE1 LRRK2 NBEA CCDC141 ELFN2

8.51e-05137746MP:0001440
MousePhenoabnormal pulmonary alveolar parenchyma morphology

SFTPA2 LRRK2 SFTPA1 GOLGA6A TRIP11

1.12e-0490745MP:0010901
MousePhenoheart right ventricle outflow tract stenosis

NTRK3 TRIP11 ZFPM2

1.30e-0419743MP:0010449
MousePhenopulmonary valve hyperplasia

NTRK3 ZFPM2

1.65e-044742MP:0031529
MousePhenosemilunar valve hyperplasia

NTRK3 ZFPM2

1.65e-044742MP:0031581
MousePhenopremature lambdoid suture closure

HDAC4 GLI3

1.65e-044742MP:0030356
MousePhenoabnormal cell motility

NEDD9 ADCY10 DNHD1 ARHGEF28 GOPC TRIO MYO9A GLI3 ACTN4 GOLGA6A ITGA5 CTTN CCDC141 WDR62

1.93e-048857414MP:0020846
DomainSpectrin

TRIO SYNE1 ACTN4 CCDC141

3.63e-0623874PF00435
DomainSpectrin_repeat

TRIO SYNE1 ACTN4 CCDC141

9.54e-0629874IPR002017
DomainPumilio_RNA-bd

PUM2 PUM1

2.14e-052872IPR033712
DomainPUM-HD

PUM2 PUM1

6.42e-053872IPR033133
DomainPUF

PUM2 PUM1

6.42e-053872PF00806
DomainPUM_HD

PUM2 PUM1

6.42e-053872PS50303
DomainPumilio_RNA-bd_rpt

PUM2 PUM1

1.28e-044872IPR001313
DomainPUM

PUM2 PUM1

1.28e-044872PS50302
DomainPumilio

PUM2 PUM1

1.28e-044872SM00025
DomainIQ

RNF32 MYO9A IQCB1 OBSCN

3.36e-0471874PF00612
DomainLRR

LRR1 NTRK3 LRRK2 SLITRK6 ELFN2 BGN

3.53e-04201876PS51450
DomainSpectrin/alpha-actinin

TRIO SYNE1 ACTN4

4.39e-0432873IPR018159
DomainSPEC

TRIO SYNE1 ACTN4

4.39e-0432873SM00150
DomainIQ

RNF32 MYO9A IQCB1 OBSCN

5.56e-0481874SM00015
DomainLRR_1

LRR1 NTRK3 LRRK2 SLITRK6 ELFN2 BGN

5.56e-04219876PF00560
DomainIQ_motif_EF-hand-BS

RNF32 MYO9A IQCB1 OBSCN

8.27e-0490874IPR000048
DomainIQ

RNF32 MYO9A IQCB1 OBSCN

9.35e-0493874PS50096
DomainLeu-rich_rpt_4

LRR1 LRRK2

9.42e-0410872IPR025875
DomainLRR_4

LRR1 LRRK2

9.42e-0410872PF12799
DomainGBP_C

ATL2 ATL1

9.42e-0410872PF02841
DomainC-type_lectin_CS

SFTPA2 ASGR1 SFTPA1

1.05e-0343873IPR018378
DomainG_GB1_RHD3_dom

ATL2 ATL1

1.15e-0311872IPR030386
DomainGuanylate-bd_C

ATL2 ATL1

1.15e-0311872IPR003191
DomainGBP

ATL2 ATL1

1.15e-0311872PF02263
DomainGuanylate-bd_N

ATL2 ATL1

1.15e-0311872IPR015894
DomainG_GB1_RHD3

ATL2 ATL1

1.15e-0311872PS51715
DomainLRR_8

NTRK3 LRRK2 SLITRK6 ELFN2 BGN

1.22e-03171875PF13855
DomainLeu-rich_rpt_typical-subtyp

LRR1 LRRK2 SLITRK6 ELFN2 BGN

1.43e-03177875IPR003591
DomainLRR_TYP

LRR1 LRRK2 SLITRK6 ELFN2 BGN

1.43e-03177875SM00369
DomainARM-like

USP9X IQCB1 LRRK2 PUM2 NBEA PUM1

1.64e-03270876IPR011989
DomainLeu-rich_rpt

LRR1 NTRK3 LRRK2 SLITRK6 ELFN2 BGN

1.67e-03271876IPR001611
DomainDH_1

ARHGEF28 TRIO OBSCN

3.17e-0363873PS00741
DomainConA-like_dom

FSD1L LAMA4 NBEA TRIM34 RYR1

3.59e-03219875IPR013320
Domain-

LRR1 NTRK3 LRRK2 SLITRK6 ELFN2 BGN

3.87e-033218763.80.10.10
DomainRhoGEF

ARHGEF28 TRIO OBSCN

3.93e-0368873SM00325
DomainCRAL_TRIO

PRUNE2 TRIO

4.25e-0321872PF00650
DomainRhoGEF

ARHGEF28 TRIO OBSCN

4.27e-0370873PF00621
DomainDH_2

ARHGEF28 TRIO OBSCN

4.27e-0370873PS50010
DomainL_dom-like

LRR1 NTRK3 LRRK2 SLITRK6 ELFN2 BGN

4.30e-03328876IPR032675
DomainDH-domain

ARHGEF28 TRIO OBSCN

4.44e-0371873IPR000219
Domain-

ARHGEF28 TRIO OBSCN

4.44e-03718731.20.900.10
DomainARM-type_fold

USP9X IQCB1 LRRK2 PUM2 NBEA PUM1

5.04e-03339876IPR016024
DomainActinin_actin-bd_CS

SYNE1 ACTN4

5.09e-0323872IPR001589
Domain-

PRUNE2 TRIO

5.09e-03238723.40.525.10
DomainACTININ_2

SYNE1 ACTN4

5.09e-0323872PS00020
DomainACTININ_1

SYNE1 ACTN4

5.09e-0323872PS00019
DomainP-loop_NTPase

ADCY10 DNHD1 MYO9A DDX60 IQCB1 LRRK2 DDX60L SLFN5 ATL2 ATL1

5.99e-038488710IPR027417
DomainSEC14

PRUNE2 TRIO

6.00e-0325872SM00516
DomainC_TYPE_LECTIN_1

SFTPA2 ASGR1 SFTPA1

6.20e-0380873PS00615
DomainCRAL_TRIO

PRUNE2 TRIO

6.98e-0327872PS50191
DomainLectin_C

SFTPA2 ASGR1 SFTPA1

7.09e-0384873PF00059
DomainCLECT

SFTPA2 ASGR1 SFTPA1

7.09e-0384873SM00034
DomainC_TYPE_LECTIN_2

SFTPA2 ASGR1 SFTPA1

7.32e-0385873PS50041
DomainCRAL-TRIO_dom

PRUNE2 TRIO

7.49e-0328872IPR001251
DomainC-type_lectin-like

SFTPA2 ASGR1 SFTPA1

7.56e-0386873IPR001304
DomainSPRY

FSD1L TRIM34 RYR1

7.81e-0387873SM00449
DomainFYVE

FYCO1 EEA1

8.03e-0329872PF01363
DomainFYVE

FYCO1 EEA1

8.03e-0329872SM00064
DomainCys-rich_flank_reg_C

NTRK3 SLITRK6 ELFN2

8.57e-0390873IPR000483
DomainLRRCT

NTRK3 SLITRK6 ELFN2

8.57e-0390873SM00082
PathwayREACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE

AKAP9 FBF1 IQCB1 CEP83 CEP164

1.20e-0496715MM15207
PathwayREACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE

AKAP9 FBF1 IQCB1 CEP83 CEP164

1.26e-0497715M27478
Pubmed

Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.

ADCY10 DNHD1 CCDC88C MYO9A CEP112 DDX60 LRRK2 FYCO1 RYR1

3.82e-0920890933230847
Pubmed

A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.

NEDD9 MAN2A2 AKAP9 TRIO RALBP1 SYNE1 OBSCN LAMA4 ACTN4 CCDC141 TRIP11 RYR1

6.35e-09497901223414517
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

CCDC88C ARHGEF28 AKAP9 HDAC4 TRIO TRPM7 MYO9A CEP112 NTRK3 IQCB1 PUM1 TRIP11 PPM1H WDR62

4.63e-08861901436931259
Pubmed

Centriole distal appendages promote membrane docking, leading to cilia initiation.

FBF1 CEP83 CEP164

1.67e-07590323348840
Pubmed

Molecular embryology of the lung: then, now, and in the future.

SFTPA2 GLI3 SFTPA1

3.33e-07690310330024
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

ZNF18 TRIO SACS TRPM7 USP9X RALBP1 SYNE1 NUCB1 NBEA RORB ACTN4 CTTN TRIP11 TXLNG KLHL4

1.02e-061285901535914814
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

CCDC88C AKAP9 HDAC4 TRIO USP9X SYNE1 CALCOCO1 NBEA FYCO1 GOLGA6A CTTN TRIP11 PPM1H

1.19e-06963901328671696
Pubmed

Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.

ABRAXAS2 CCDC88C AKAP9 HDAC4 USP9X FBF1 PUM1 PPM1H WDR62

2.44e-0644690924255178
Pubmed

Airway epithelial cell differentiation during lung organogenesis requires C/EBPα and C/EBPβ.

SFTPA2 CEBPG SFTPA1

5.97e-061490322411169
Pubmed

TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.

LRR1 TBRG4 SFTPA2 USP9X PHF12 FBF1 NBEA ITGA5 TRIP11 RYR1

6.16e-06638901031182584
Pubmed

Major Effect of Oxidative Stress on the Male, but Not Female, SP-A1 Type II Cell miRNome.

SFTPA2 SFTPA1

6.62e-06290231354704
Pubmed

Signaling Pathways That Mediate Alveolar Macrophage Activation by Surfactant Protein A and IL-4.

SFTPA2 SFTPA1

6.62e-06290235444643
Pubmed

Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo.

SFTPA2 SFTPA1

6.62e-06290210749762
Pubmed

The flagellum of Pseudomonas aeruginosa is required for resistance to clearance by surfactant protein A.

SFTPA2 SFTPA1

6.62e-06290217593964
Pubmed

Studies of the structure of lung surfactant protein SP-A.

SFTPA2 SFTPA1

6.62e-0629022610270
Pubmed

Surfactant protein-A binds group B streptococcus enhancing phagocytosis and clearance from lungs of surfactant protein-A-deficient mice.

SFTPA2 SFTPA1

6.62e-0629029922219
Pubmed

Maternal surfactant protein A influences the immunoprotective properties of milk in a murine model.

SFTPA2 SFTPA1

6.62e-06290224858142
Pubmed

Surfactant protein-A--deficient mice display an exaggerated early inflammatory response to a beta-resistant strain of influenza A virus.

SFTPA2 SFTPA1

6.62e-06290211867335
Pubmed

Pneumocystis murina colonization in immunocompetent surfactant protein A deficient mice following environmental exposure.

SFTPA2 SFTPA1

6.62e-06290219228388
Pubmed

SP-A preserves airway homeostasis during Mycoplasma pneumoniae infection in mice.

SFTPA2 SFTPA1

6.62e-06290219494306
Pubmed

An 11-nt sequence polymorphism at the 3'UTR of human SFTPA1 and SFTPA2 gene variants differentially affect gene expression levels and miRNA regulation in cell culture.

SFTPA2 SFTPA1

6.62e-06290224793167
Pubmed

Sex differences in the acute in vivo effects of different human SP-A variants on the mouse alveolar macrophage proteome.

SFTPA2 SFTPA1

6.62e-06290224954098
Pubmed

Characterization of a second human pulmonary surfactant-associated protein SP-A gene.

SFTPA2 SFTPA1

6.62e-0629021372511
Pubmed

Lung effector memory and activated CD4+ T cells display enhanced proliferation in surfactant protein A-deficient mice during allergen-mediated inflammation.

SFTPA2 SFTPA1

6.62e-06290221257967
Pubmed

The Pseudomonas aeruginosa flagellum confers resistance to pulmonary surfactant protein-A by impacting the production of exoproteases through quorum-sensing.

SFTPA2 SFTPA1

6.62e-06290221205009
Pubmed

Surfactant protein A modulates neuroinflammation in adult mice upon pulmonary infection.

SFTPA2 SFTPA1

6.62e-06290238964703
Pubmed

Differential Regulation of Human Surfactant Protein A Genes, SFTPA1 and SFTPA2, and Their Corresponding Variants.

SFTPA2 SFTPA1

6.62e-06290234917085
Pubmed

Surfactant protein A integrates activation signal strength to differentially modulate T cell proliferation.

SFTPA2 SFTPA1

6.62e-06290222219327
Pubmed

Surfactant protein A is a principal and oxidation-sensitive microbial permeabilizing factor in the alveolar lining fluid.

SFTPA2 SFTPA1

6.62e-06290215890661
Pubmed

Enhanced lung injury and delayed clearance of Pneumocystis carinii in surfactant protein A-deficient mice: attenuation of cytokine responses and reactive oxygen-nitrogen species.

SFTPA2 SFTPA1

6.62e-06290215385504
Pubmed

A TLR4-interacting SPA4 peptide inhibits LPS-induced lung inflammation.

SFTPA2 SFTPA1

6.62e-06290223475791
Pubmed

Surfactant protein A associated with respiratory distress syndrome in Korean preterm infants: evidence of ethnic difference.

SFTPA2 SFTPA1

6.62e-06290223038062
Pubmed

Surfactant protein A binds flagellin enhancing phagocytosis and IL-1β production.

SFTPA2 SFTPA1

6.62e-06290224312669
Pubmed

Correlation analysis between single nucleotide polymorphisms of pulmonary surfactant protein A gene and pulmonary tuberculosis in the Han population in China.

SFTPA2 SFTPA1

6.62e-06290224984162
Pubmed

Effect of cysteine 85 on biochemical properties and biological function of human surfactant protein A variants.

SFTPA2 SFTPA1

6.62e-06290217580966
Pubmed

Cloning and comparative sequence analysis of PUM1 and PUM2 genes, human members of the Pumilio family of RNA-binding proteins.

PUM2 PUM1

6.62e-06290212459267
Pubmed

Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins.

PUM2 PUM1

6.62e-06290229165587
Pubmed

NEDD9 is transcriptionally regulated by HDAC4 and promotes breast cancer metastasis and macrophage M2 polarization via the FAK/NF-κB signaling pathway.

NEDD9 HDAC4

6.62e-06290239326322
Pubmed

Isolation and characterization of cDNA clones for the 35-kDa pulmonary surfactant-associated protein.

SFTPA2 SFTPA1

6.62e-0629023755136
Pubmed

Differential effects of innate immune variants of surfactant protein-A1 (SFTPA1) and SP-A2 (SFTPA2) in airway function after Klebsiella pneumoniae infection and sex differences.

SFTPA2 SFTPA1

6.62e-06290229394894
Pubmed

Surfactant protein-A suppresses eosinophil-mediated killing of Mycoplasma pneumoniae in allergic lungs.

SFTPA2 SFTPA1

6.62e-06290222384248
Pubmed

Surfactant protein A enhances production of secretory leukoprotease inhibitor and protects it from cleavage by matrix metalloproteinases.

SFTPA2 SFTPA1

6.62e-06290219155504
Pubmed

Surfactant Protein A can Affect the Surface Tension of the Eustachian Tube and Macrophage Migration.

SFTPA2 SFTPA1

6.62e-06290236102297
Pubmed

Role of surfactant protein-A (SP-A) in lung injury in response to acute ozone exposure of SP-A deficient mice.

SFTPA2 SFTPA1

6.62e-06290217307210
Pubmed

PUMILIO-mediated translational control of somatic cell cycle program promotes folliculogenesis and contributes to ovarian cancer progression.

PUM2 PUM1

6.62e-06290235507203
Pubmed

Bespoke RNA recognition by Pumilios.

PUM2 PUM1

6.62e-06290226517885
Pubmed

Surfactant protein A modulates induction of regulatory T cells via TGF-β.

SFTPA2 SFTPA1

6.62e-06290222474025
Pubmed

Mouse Pum1 and Pum2 genes, members of the Pumilio family of RNA-binding proteins, show differential expression in fetal and adult hematopoietic stem cells and progenitors.

PUM2 PUM1

6.62e-06290212667987
Pubmed

Genome-wide comparison of human keratinocyte and squamous cell carcinoma responses to UVB irradiation: implications for skin and epithelial cancer.

PUM2 PUM1

6.62e-06290212771951
Pubmed

Reconstitution of human atlastin fusion activity reveals autoinhibition by the C terminus.

ATL2 ATL1

6.62e-06290234817557
Pubmed

The collagen-like region of surfactant protein A (SP-A) is required for correction of surfactant structural and functional defects in the SP-A null mouse.

SFTPA2 SFTPA1

6.62e-06290211504713
Pubmed

Surfactant protein A promotes western diet-induced hepatic steatosis and fibrosis in mice.

SFTPA2 SFTPA1

6.62e-06290238553537
Pubmed

Alternate modes of cognate RNA recognition by human PUMILIO proteins.

PUM2 PUM1

6.62e-06290221397187
Pubmed

Surfactant protein A reduces TLR4 and inflammatory cytokine mRNA levels in neonatal mouse ileum.

SFTPA2 SFTPA1

6.62e-06290233510368
Pubmed

Genetic complexity of the human innate host defense molecules, surfactant protein A1 (SP-A1) and SP-A2--impact on function.

SFTPA2 SFTPA1

6.62e-06290219392648
Pubmed

Polymorphisms in the surfactant protein a gene are associated with the susceptibility to recurrent urinary tract infection in chinese women.

SFTPA2 SFTPA1

6.62e-06290220448439
Pubmed

Humanized SFTPA1 and SFTPA2 transgenic mice reveal functional divergence of SP-A1 and SP-A2: formation of tubular myelin in vivo requires both gene products.

SFTPA2 SFTPA1

6.62e-06290220048345
Pubmed

Functional assessment and phenotypic heterogeneity of SFTPA1 and SFTPA2 mutations in interstitial lung diseases and lung cancer.

SFTPA2 SFTPA1

6.62e-06290232855221
Pubmed

Surfactant protein A suppresses lipopolysaccharide-induced IL-10 production by murine macrophages.

SFTPA2 SFTPA1

6.62e-06290211342662
Pubmed

Surfactant protein A-deficient mice are susceptible to group B streptococcal infection.

SFTPA2 SFTPA1

6.62e-0629029126996
Pubmed

Type IV pilus of Pseudomonas aeruginosa confers resistance to antimicrobial activities of the pulmonary surfactant protein-A.

SFTPA2 SFTPA1

6.62e-06290224080545
Pubmed

Lung development in the mouse embryo.

SFTPA2 SFTPA1

6.62e-0629022050021
Pubmed

Murine pulmonary surfactant SP-A gene: cloning, sequence, and transcriptional activity.

SFTPA2 SFTPA1

6.62e-0629021443158
Pubmed

Surfactant Protein A and B Gene Polymorphisms and Risk of Respiratory Distress Syndrome in Late-Preterm Neonates.

SFTPA2 SFTPA1

6.62e-06290227835691
Pubmed

Genetic Variation in Surfactant Protein-A2 Delays Resolution of Eosinophilia in Asthma.

SFTPA2 SFTPA1

6.62e-06290231350355
Pubmed

Genetic complexity of the human surfactant-associated proteins SP-A1 and SP-A2.

SFTPA2 SFTPA1

6.62e-06290223069847
Pubmed

Ablation of SP-A has a negative impact on the susceptibility of mice to Klebsiella pneumoniae infection after ozone exposure: sex differences.

SFTPA2 SFTPA1

6.62e-06290219055785
Pubmed

Human Surfactant Protein SP-A1 and SP-A2 Variants Differentially Affect the Alveolar Microenvironment, Surfactant Structure, Regulation and Function of the Alveolar Macrophage, and Animal and Human Survival Under Various Conditions.

SFTPA2 SFTPA1

6.62e-06290234484180
Pubmed

Pathogenic LRRK2 control of primary cilia and Hedgehog signaling in neurons and astrocytes of mouse brain.

LRRK2 PPM1H

6.62e-06290234658337
Pubmed

Surfactant protein A limits Pneumocystis murina infection in immunosuppressed C3H/HeN mice and modulates host response during infection.

SFTPA2 SFTPA1

6.62e-06290215857803
Pubmed

Surfactant protein-A reduces translocation of mediators from the lung into the circulation.

SFTPA2 SFTPA1

6.62e-06290220715984
Pubmed

A Quantitative and Predictive Model for RNA Binding by Human Pumilio Proteins.

PUM2 PUM1

6.62e-06290231078383
Pubmed

Effects of surfactant protein-A on the interaction of Pneumocystis murina with its host at different stages of the infection in mice.

SFTPA2 SFTPA1

6.62e-06290219335775
Pubmed

Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas.

PRUNE2 OBSCN

6.62e-06290217360660
Pubmed

Altered surfactant protein A gene expression and protein metabolism associated with repeat exposure to inhaled endotoxin.

SFTPA2 SFTPA1

6.62e-06290212922979
Pubmed

Cryptococcus neoformans is resistant to surfactant protein A mediated host defense mechanisms.

SFTPA2 SFTPA1

6.62e-06290218159253
Pubmed

Principles of mRNA control by human PUM proteins elucidated from multimodal experiments and integrative data analysis.

PUM2 PUM1

6.62e-06290232753408
Pubmed

Differences in the alveolar macrophage toponome in humanized SP-A1 and SP-A2 transgenic mice.

SFTPA2 SFTPA1

6.62e-06290233141765
Pubmed

Localization of PPM1H phosphatase tunes Parkinson's disease-linked LRRK2 kinase-mediated Rab GTPase phosphorylation and ciliogenesis.

LRRK2 PPM1H

6.62e-06290237889931
Pubmed

Regulatory roles of SP-A and exosomes in pneumonia-induced acute lung and kidney injuries.

SFTPA2 SFTPA1

6.62e-06290237256132
Pubmed

Surfactant protein a attenuates generalized and localized neuroinflammation in neonatal mice.

SFTPA2 SFTPA1

6.62e-06290236871846
Pubmed

Innate immunity of surfactant protein A in experimental otitis media.

SFTPA2 SFTPA1

6.62e-06290231378117
Pubmed

Surfactant Protein A, a Novel Regulator for Smooth Muscle Phenotypic Modulation and Vascular Remodeling-Brief Report.

SFTPA2 SFTPA1

6.62e-06290233267655
Pubmed

PUMILIO proteins promote colorectal cancer growth via suppressing p21.

PUM2 PUM1

6.62e-06290235338151
Pubmed

Effects of PUMILIO1 and PUMILIO2 knockdown on cardiomyogenic differentiation of human embryonic stem cells culture.

PUM2 PUM1

6.62e-06290232437472
Pubmed

Immunosuppressed surfactant protein A-deficient mice have increased susceptibility to Pneumocystis carinii infection.

SFTPA2 SFTPA1

6.62e-06290211237812
Pubmed

Human SP-A protein variants derived from one or both genes stimulate TNF-alpha production in the THP-1 cell line.

SFTPA2 SFTPA1

6.62e-06290210781424
Pubmed

SP-A is necessary for increased clearance of alveolar DPPC with hyperventilation or secretagogues.

SFTPA2 SFTPA1

6.62e-06290212676766
Pubmed

Surfactant protein A deficiency exacerbates renal interstitial fibrosis following obstructive injury in mice.

SFTPA2 SFTPA1

6.62e-06290227916681
Pubmed

Surfactant protein A inhibits alveolar macrophage cytokine production by CD14-independent pathway.

SFTPA2 SFTPA1

6.62e-06290212959932
Pubmed

Surfactant protein secreted by the maturing mouse fetal lung acts as a hormone that signals the initiation of parturition.

SFTPA2 SFTPA1

6.62e-06290215044702
Pubmed

AKAP9 regulation of microtubule dynamics promotes Epac1-induced endothelial barrier properties.

AKAP9 RAPGEF3

6.62e-06290220952690
Pubmed

Structural comparison of recombinant pulmonary surfactant protein SP-A derived from two human coding sequences: implications for the chain composition of natural human SP-A.

SFTPA2 SFTPA1

6.62e-0629021986781
Pubmed

Surfactant protein A is a required mediator of keratinocyte growth factor after experimental marrow transplantation.

SFTPA2 SFTPA1

6.62e-06290212740217
Pubmed

Surfactant protein-A plays an important role in lung surfactant clearance: evidence using the surfactant protein-A gene-targeted mouse.

SFTPA2 SFTPA1

6.62e-06290218083768
Pubmed

Structural characterisation of human proteinosis surfactant protein A.

SFTPA2 SFTPA1

6.62e-06290211087951
Pubmed

Comparative analysis of mRNA targets for human PUF-family proteins suggests extensive interaction with the miRNA regulatory system.

PUM2 PUM1

6.62e-06290218776931
Pubmed

Surfactant protein-A inhibits Aspergillus fumigatus-induced allergic T-cell responses.

SFTPA2 SFTPA1

6.62e-06290216120217
Pubmed

SP-A2 contributes to miRNA-mediated sex differences in response to oxidative stress: pro-inflammatory, anti-apoptotic, and anti-oxidant pathways are involved.

SFTPA2 SFTPA1

6.62e-06290229202868
Pubmed

The alveolar macrophage toponome of female SP-A knockout mice differs from that of males before and after SP-A1 rescue.

SFTPA2 SFTPA1

6.62e-06290235322074
InteractionPCM1 interactions

AKAP9 HDAC4 MYO9A CEP112 USP9X RALBP1 FBF1 IQCB1 GOLGA6A EEA1 TXLNG CEP164

4.00e-074348812int:PCM1
InteractionSFN interactions

CCDC88C ARHGEF28 AKAP9 HDAC4 TRPM7 MYO9A CEP112 NTRK3 LRRK2 EEA1 PUM1 TRIP11 WDR62

9.25e-066928813int:SFN
InteractionKRT38 interactions

CEBPG HDAC4 MYO9A FYCO1 EEA1 TXLNG CEP164

1.04e-05172887int:KRT38
InteractionANPEP interactions

GOPC TRPM7 USP9X NADK2 NBEA ACTN4 TRIP11

1.12e-05174887int:ANPEP
InteractionGUSBP5 interactions

PHF12 IQCB1 PUM2 PUM1 CEP164

1.92e-0575885int:GUSBP5
GeneFamilyCollectins

SFTPA2 SFTPA1

4.32e-0410572491
CoexpressionLAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2

NEDD9 PRUNE2 MYO9A CEP112 SYNE1 ZFPM2

5.22e-0786906M39248
CoexpressionGSE9946_IMMATURE_VS_LISTERIA_INF_MATURE_DC_UP

GOPC LRRK2 OBSCN SFTPA1 NBEA CRACR2B

8.98e-06140906M418
CoexpressionRAPA_EARLY_UP.V1_UP

ADCY10 CCDC88C NUCB1 GREB1 ITGA5 ST8SIA3

2.45e-05167906M2644
CoexpressionAtlasDevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000

NEDD9 ARHGEF28 AKAP9 TRIO TRPM7 USP9X RALBP1 ATL2 CEP164

1.37e-05339909gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5
CoexpressionAtlasDevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000

ARHGEF28 AKAP9 GOPC USP9X RALBP1 ATL2 CCDC141 CEP164

1.52e-05261908gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 MYO9A SYNE1 GLI3 CFAP221 LRRK2 PPM1H

1.03e-07186907f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NEDD9 PRUNE2 TRIO MYO9A SYNE1 LRRK2 PPM1H

1.11e-0718890763a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68
ToppCell(02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition

AKAP9 RALBP1 GOLIM4 PARP9 SLFN5 EEA1 TRIP11

1.63e-0719990718a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

PRUNE2 SACS NTRK3 LAMA4 ITGA5 ZFPM2

1.41e-06173906cb6389536195443633adb06e5f1b7483530773d1
ToppCelldroplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRPM7 MYO9A CEP112 GOLIM4 TRIP11 ZNF260

1.56e-06176906749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NEDD9 PRUNE2 MYO9A SYNE1 LRRK2 PPM1H

1.56e-06176906327a3e81b724252e36d786de92a3ffd721ea6d7b
ToppCellControl-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations)

SFTPA2 SYNE1 CFAP221 LRRK2 SFTPA1 CCDC141

1.78e-06180906198b19e7910b4a8cc7e820c525ab357c7f99f578
ToppCellCalu_3-infected|Calu_3 / Cell line, Condition and Strain

TRIO USP9X DDX60 PARP9 DDX60L SLFN5

1.96e-061839068f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 MYO9A GLI3 CFAP221 LRRK2 PPM1H

2.22e-06187906c31130fc2f9f882944b2ba366a034a03f051c4b9
ToppCellAT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id

SFTPA2 TMEM191B CFAP221 LRRK2 SFTPA1 CTTN

2.36e-061899062d32f09efa982ae458568f6b1cd06bb5078d42a3
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

NEDD9 TRIO MYO9A CFAP221 LRRK2 PPM1H

2.51e-06191906d0e9afe7b6334dd515d3e68892efdc76347a55e5
ToppCellnucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

SFTPA2 SYNE1 CFAP221 LRRK2 SFTPA1 CCDC141

2.66e-06193906fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf
ToppCellnucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

SFTPA2 SYNE1 CFAP221 LRRK2 SFTPA1 CCDC141

2.66e-06193906f3cc7cfdbc164a4ed42f87647111522b7d393bcb
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ARHGEF28 MYO9A SYNE1 CFAP221 LRRK2 PPM1H

2.74e-06194906e577d9e88390b36b5a09b97fe1026089892275a3
ToppCellnucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

GLI3 NTRK3 OBSCN LAMA4 ZFPM2 BGN

2.74e-061949062d66091097e106c7bee22e5281f50724700bdf8d
ToppCellnucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

SFTPA2 MYO9A SYNE1 LRRK2 SFTPA1 CCDC141

2.74e-0619490653f3e49e91b1096f3226010e2de767efb490dfe4
ToppCellnucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

SFTPA2 MYO9A SYNE1 CFAP221 LRRK2 SFTPA1

2.82e-061959069406866f99555198a9be311fbd65751b70f35446
ToppCellControl_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type

FSD1L ARHGEF28 SFTPA2 AKAP9 LRRK2 CCDC141

2.99e-0619790644a59dfb889577b3160a5b13ada1276771a00241
ToppCellLPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

FSD1L ARHGEF28 SFTPA2 AKAP9 LRRK2 CCDC141

2.99e-061979061485933986921ff45669d9b7501c8d17050b3e97
ToppCellLPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

FSD1L ARHGEF28 SFTPA2 AKAP9 LRRK2 CCDC141

3.08e-06198906285f729140b1df029c24f6ca1d2438470ac51794
ToppCell(10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition

AKAP9 RALBP1 PARP9 SLFN5 EEA1 TRIP11

3.17e-0619990661b1ed2db71b96157b92b7535d1955a4033098da
ToppCell(04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition

AKAP9 RALBP1 PARP9 SLFN5 EEA1 TRIP11

3.17e-0619990653ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell(03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition

AKAP9 RALBP1 PARP9 SLFN5 EEA1 TRIP11

3.17e-06199906c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell(05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition

AKAP9 RALBP1 PARP9 SLFN5 EEA1 TRIP11

3.17e-06199906d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098
ToppCell(01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition

NEDD9 AKAP9 GOLIM4 SLFN5 EEA1 TRIP11

3.17e-06199906a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCellLPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

FSD1L ARHGEF28 SFTPA2 AKAP9 LRRK2 CCDC141

3.27e-06200906e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae
ToppCellLPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

PRUNE2 SYNE1 LAMA4 SLITRK6 ZFPM2 BGN

3.27e-0620090608bf8c00eee6468215edb3611296bfc8784c4d56
ToppCellLPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type

PRUNE2 SYNE1 LAMA4 SLITRK6 ZFPM2 BGN

3.27e-0620090602cae2c296a13ad4cbb53bca7a86d64629d67d66
ToppCellLPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

PRUNE2 SYNE1 NTRK3 LAMA4 ZFPM2 BGN

3.27e-06200906dcdaec3ca3a3024dc1b8788c417003f84c2bffdc
ToppCellThalamus|World / BrainAtlas - Mouse McCarroll V32

CFAP221 RORB SLITRK6 CCDC141 TRIP11

3.85e-061169055ddfb2dd5459ff6d7ae38163a38eae64fda283b7
ToppCell(08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition

AKAP9 RALBP1 PARP9 SLFN5 TRIP11

9.00e-06138905817e3f639604ea95adae01e8685ffaa2e0aff7a8
ToppCellMS-CD4-antiviral_CD4|MS / Condition, Cell_class and T cell subcluster

ADCY10 DDX60 PARP9 DDX60L SLFN5

1.44e-05152905b1eba2d5a6da3eeb83d40a92976e3e8751ed18ee
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SACS RAPGEF3 SYNE1 ZFPM2 BGN

1.63e-05156905dd41ed918b07fa248da458a629b3c53cb7ea8764
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SACS RAPGEF3 SYNE1 ZFPM2 BGN

1.63e-05156905abf9dd075b1ca8f613c660cc82f8a5af071fb6ab
ToppCell368C-Epithelial_cells-Epithelial-A_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells)

SFTPA2 LRRK2 SFTPA1 CCDC141 ELFN2

2.07e-0516490585f53d184fa70e3eb1af655807f32b17ddbfb304
ToppCell368C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

ADCY10 ARHGEF28 NTRK3 SLITRK6 CCDC141

2.07e-05164905dd29decc6c41a580cfdf03962827ec18d432935f
ToppCell368C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

ADCY10 ARHGEF28 NTRK3 SLITRK6 CCDC141

2.07e-05164905dcd3c3ee73900180451fad9b4de0efedbd375e1c
ToppCell368C-Epithelial_cells-Epithelial-A_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells)

SFTPA2 LRRK2 SFTPA1 CCDC141 ELFN2

2.07e-05164905144ba070a1ede71684224cc6d4ead3b7e6a7b4c6
ToppCellBrain_organoid-organoid_Kanton_Nature-Organoid-4M-Stem_cells-neuroepithelial-like_cells|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.

RNF32 WHRN CFAP221 OBSCN CRACR2B

2.26e-05167905e488d9c7cf4355959e3833de3bd496c13fc11b1b
ToppCellControl-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations)

NTRK3 OBSCN LAMA4 ZFPM2 BGN

2.53e-05171905080003f698f867935c2bfc55d241d3650f45a0ab
ToppCellCOVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type

PRUNE2 SACS SYNE1 LAMA4 ZFPM2

2.60e-0517290536a96714a0eb6ac438648135336c9791881ddadb
ToppCellkidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

RNF32 PRUNE2 SACS LRRK2 TFAP2C

2.91e-0517690533323c97afe509147956b8df9f92ca6b0537e604
ToppCell368C-Epithelial_cells-Epithelial-B_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells)

SFTPA2 LRRK2 SFTPA1 RORB CCDC141

2.99e-05177905ac8f774596068e66c0a9ea8a318be0ce5f5df834
ToppCell368C-Epithelial_cells-Epithelial-B_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells)

SFTPA2 LRRK2 SFTPA1 RORB CCDC141

2.99e-05177905d9c4a93b0e04a13bf39992dd1c1ec8df2c5f89fe
ToppCelldroplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CCDC88C AKAP9 SYNE1 SLFN5 TRIP11

3.07e-0517890501dafd19de04eff459253eaa9a35debf8f3deedf
ToppCellCOVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type

PRUNE2 ARHGEF28 MYO9A RAPGEF3 PPM1H

3.07e-05178905544379f5a6145429762258d426b876bb36c112f5
ToppCellControl-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations)

PRUNE2 NTRK3 LAMA4 ITGA5 ZFPM2

3.24e-05180905d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

NEDD9 MYO9A CFAP221 LRRK2 PPM1H

3.32e-051819056a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 MYO9A CFAP221 LRRK2 PPM1H

3.32e-051819059d782ba5cf5a172cb4f447763fc50e5b13ef7dd9
ToppCellRV|World / Chamber and Cluster_Paper

AKAP9 TRPM7 OBSCN LAMA4 CCDC141

3.32e-05181905bbe1e6e59d8889bd37d6e8303116cbdcafca7236
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

NEDD9 PRUNE2 MYO9A LRRK2 ADGRF4

3.32e-051819056956ecd6264f7469a25e555673bce4eb97d28f7a
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

NEDD9 RAPGEF3 SYNE1 ZFPM2 BGN

3.32e-051819055f2d3a08577c440c944778d07aa993c6e7873f3d
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

NEDD9 RAPGEF3 SYNE1 ZFPM2 BGN

3.32e-05181905c7c5f7d4c397b4613c772413a0a679377efffff3
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 MYO9A CFAP221 LRRK2 PPM1H

3.41e-05182905eb138aa1dca9373f1586600f258df06dcf56d81f
ToppCelldroplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LAMA4 NBEA CRACR2B ZFPM2 BGN

3.41e-05182905b1ec2015aad1181eac1bbf8d48ad6f2f7ed24a01
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

NEDD9 PRUNE2 MYO9A LRRK2 PPM1H

3.50e-05183905738e94b50c4c08c727d4eed0708dda08aa6891b4
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

SFTPA2 CFAP221 LRRK2 SFTPA1 CCDC141

3.50e-051839056847c1252d6bb105524f812658112517fd351eab
ToppCellCOPD-Epithelial-ATII|World / Disease state, Lineage and Cell class

SFTPA2 SYNE1 LRRK2 SFTPA1 CCDC141

3.50e-051839058e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

NEDD9 MYO9A SYNE1 CFAP221 PPM1H

3.50e-05183905cfae90c309622b5d499e62a3a8a8b9746478d28d
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

NEDD9 PRUNE2 MYO9A LRRK2 PPM1H

3.50e-0518390592fbd83a9d13ee91065cbd479fb298f1fd564568
ToppCellPosterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Rorb-Excitatory_Neuron.Slc17a7-Slc17a6.Rorb-Pcdh20_(Layer_5a)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

WHRN CFAP221 RORB ADGRF4

3.50e-05919041fa597c5fa4523b18fa386ee19237b82778bb1cb
ToppCellCOVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations)

SFTPA2 CFAP221 LRRK2 SFTPA1 CCDC141

3.59e-05184905369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

NEDD9 MYO9A CFAP221 LRRK2 PPM1H

3.59e-05184905da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8
ToppCell5'-Adult-Appendix-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ASGR1 SYNE1 LAMA4 ZFPM2 KLHL4

3.59e-05184905453295362888c9a59d0e73c7a5b15914c50ff591
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

LAMA4 SLITRK6 UNC80 ZFPM2 BGN

3.69e-051859059f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec
ToppCelldroplet-Lung-LUNG-30m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LAMA4 NBEA ZFPM2 ATL1 KLHL4

3.78e-05186905f23f21781a758541f59c06efa7739d26a03fb478
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

NEDD9 MYO9A CFAP221 LRRK2 PPM1H

3.78e-051869053dae539cce15fcf2b1b32e981d7febe94c03c600
ToppCelldroplet-Lung-LUNG-30m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LAMA4 NBEA ZFPM2 ATL1 KLHL4

3.78e-051869050de87109da9324c597fadf2eb782f0f158afe832
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

LAMA4 SLITRK6 UNC80 ZFPM2 BGN

3.88e-0518790513731298bc562ec29582f5da1b4c97261284f6f1
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 MYO9A CFAP221 LRRK2 PPM1H

3.88e-05187905c41a2c81dd2ceef303f39f699032aa7d6ea67cf0
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 MYO9A CFAP221 LRRK2 PPM1H

3.98e-05188905af740fa78542438fdff627ea1f74f4eee43316be
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

NEDD9 PRUNE2 MYO9A LRRK2 PPM1H

4.08e-05189905904b8337e2cabac2f0bf5dad5598fc429581ed81
ToppCellLPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PRUNE2 SYNE1 NTRK3 ZFPM2 BGN

4.08e-051899057ab1cfc1657277858339f7258a0c4ae9cb42fdf8
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

NEDD9 MYO9A CFAP221 LRRK2 PPM1H

4.08e-051899051ecf9911ff82e0ca0f0c101b735d3b1f3b339d57
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NEDD9 TRIO LAMA4 ACTN4 PPM1H

4.08e-051899058c8ca3b30d9be6c854615459a7bfba82b427c8bc
ToppCelldroplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FSD1L RAPGEF3 LAMA4 ZFPM2 BGN

4.08e-05189905ce5b3d53c9a5457a5a02b221dee18334b5eaf8b7
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NEDD9 TRIO LAMA4 ACTN4 PPM1H

4.08e-051899055d902a4660a27548764bf04c6de152b565da835c
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

NEDD9 PRUNE2 MYO9A LRRK2 TFAP2C

4.08e-05189905bd91bdfe35294e60d980259b70fe9e60dca2743f
ToppCellCOVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type

SFTPA2 CFAP221 LRRK2 SFTPA1 CCDC141

4.19e-0519090527a1a86620fe9b5ee930d388b32352206485e6d0
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MYO9A SYNE1 CFAP221 LRRK2 PPM1H

4.19e-051909053fc9e18c7441c0ae8cda65753cc42d0520f4e116
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

NEDD9 SYNE1 GOLIM4 RORB ACTN4

4.29e-0519190504faa7d2237e45418611153294eb6f7bb690cbde
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor

SFTPA2 CFAP221 LRRK2 SFTPA1 CCDC141

4.29e-05191905a0332a4ef629510fb313ec119195c44a3f704a80
ToppCellCOVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type

SFTPA2 CFAP221 LRRK2 SFTPA1 CCDC141

4.29e-05191905276455a64c2c3503d5048615762eb2ee37f0ac70
ToppCellLPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PRUNE2 SYNE1 NTRK3 ZFPM2 BGN

4.29e-0519190508042952431ca1a6fd7dfc13f36eb28643979598
ToppCellhuman_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells)

NEDD9 ARHGEF28 AKAP9 GREB1 PUM1

4.40e-05192905916fbec1c7ab7969bda711886ac88e877e30c280
ToppCellEpithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor

SFTPA2 CFAP221 LRRK2 SFTPA1 CCDC141

4.40e-0519290558c3737be7acce39fd2b91d70d6d7b2bbaa4f710
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor

SFTPA2 CFAP221 LRRK2 SFTPA1 CCDC141

4.40e-0519290506013a07e3a873b1d1c0451643c528593ac32a9c
ToppCellTCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9

AKAP9 USP9X PUM1 TRIP11 ZNF260

4.51e-05193905abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor

SFTPA2 CFAP221 LRRK2 SFTPA1 CCDC141

4.51e-05193905738f4f0a9ddde2432b429ab46838e353b1790589
ToppCellnucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

GLI3 NTRK3 LAMA4 ZFPM2 BGN

4.51e-051939055de87fc94a6e58899ef4124cf4887ed3ff96163a
ToppCellcellseq2-Epithelial-Epithelial_Alveolar-AT2-AT2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

SFTPA2 MYO9A FBF1 LRRK2 SFTPA1

4.62e-05194905df835578d86a49ae5af5632152fbab9548c0a448
ToppCellcellseq2-Epithelial-Epithelial_Alveolar|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

SFTPA2 MYO9A FBF1 LRRK2 SFTPA1

4.62e-051949050715f2d55f4a6d2edda1b3dc52f12d25ce59eb10
ToppCell10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

TRIO SACS NADK2 GOLIM4 KLHL4

4.62e-051949058b81f039f5b25d35a4d5a41b27d4d9360ba22f15
ToppCellcellseq2-Epithelial-Epithelial_Alveolar-AT2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

SFTPA2 MYO9A FBF1 LRRK2 SFTPA1

4.62e-05194905a4f7cd507eba40985d82635bbae28c7f5703f883
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

WHRN TRIO CFAP221 ELFN2 PPM1H

4.74e-05195905938b31dbf1674ee6fd0123bc88391ddcaf151217
ToppCellControl-Multiplet|Control / Disease state, Lineage and Cell class

SFTPA2 SYNE1 CFAP221 SFTPA1 CTTN

4.74e-05195905618900c80bea09d46dad3f741bd1bff8bf0a64ee
ToppCellAT2_cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id

SFTPA2 SYNE1 LRRK2 SFTPA1 CCDC141

4.74e-051959050792c1e959e933b10ae987d821ff43020dfdabad
ToppCellAT2_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id

SFTPA2 LRRK2 SFTPA1 RORB CCDC141

4.74e-0519590533f60762f00cd6f4757d8a8d5227141558ac823e
ToppCellAT2_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id

SFTPA2 SYNE1 LRRK2 SFTPA1 CCDC141

4.74e-05195905b0cea3f4e59635913d243612f2e8cf4c7b34e726
ToppCell343B|World / Donor, Lineage, Cell class and subclass (all cells)

SFTPA2 CFAP221 LRRK2 SFTPA1 RORB

4.74e-051959052290911fde6efacfa38b985a2541322968bee42d
DrugSulfamerazine [127-79-7]; Up 200; 15.2uM; MCF7; HT_HG-U133A

RNF32 WHRN TRIO GREB1 ST8SIA3 CEP164 WDR62

1.33e-051979073616_UP
DrugOxantel pamoate [68813-55-8]; Down 200; 6.6uM; PC3; HT_HG-U133A

WHRN TRIO DDX60 ST8SIA3 TFAP2C TAFAZZIN WDR62

1.37e-051989076738_DN
DrugSuxibuzone [27470-51-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A

PRUNE2 AKAP9 HDAC4 CALCOCO1 LAMA4 EEA1 ST8SIA3

1.42e-051999077163_UP
DrugEnilconazole [35554-44-0]; Up 200; 13.4uM; MCF7; HT_HG-U133A

ADCY10 MAN2A2 ADAM20 CALCOCO1 LAMA4 GREB1 WDR62

1.47e-052009076518_UP
Diseasehereditary spastic paraplegia 3A (implicated_via_orthology)

ATL2 ATL1

2.51e-053862DOID:0110791 (implicated_via_orthology)
DiseaseIntellectual Disability

HDAC4 TRIO SACS SYNE1 NBEA PUM1 ATL1 WDR62

4.92e-05447868C3714756
Diseaselevel of leukocyte immunoglobulin-like receptor subfamily B member 4 in blood serum

SFTPA2 SFTPA1

8.35e-055862OBA_2042200
Diseaselevel of prosaposin in blood serum

SFTPA2 SFTPA1

8.35e-055862OBA_2044552
Diseasenewborn respiratory distress syndrome (biomarker_via_orthology)

SFTPA2 SFTPA1

1.25e-046862DOID:12716 (biomarker_via_orthology)
Diseasenewborn respiratory distress syndrome (is_implicated_in)

SFTPA2 SFTPA1

1.75e-047862DOID:12716 (is_implicated_in)
Diseaseattention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia

HDAC4 SYNE1 NTRK3 ZFPM2

2.21e-04101864EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090
Diseaseleukocyte immunoglobulin-like receptor subfamily B member 4 measurement

SFTPA2 SFTPA1

2.32e-048862EFO_0801768
DiseaseDickkopf-related protein 4 measurement

CEP112 ZFPM2

2.32e-048862EFO_0008110
Diseasechronic obstructive pulmonary disease, chronic bronchitis

CFAP221 CRACR2B

3.72e-0410862EFO_0000341, EFO_0006505
Diseasecomplement C1q tumor necrosis factor-related protein 1 measurement

SFTPA2 SFTPA1

5.44e-0412862EFO_0801493
DiseaseRenal dysplasia and retinal aplasia (disorder)

IQCB1 CEP164

5.44e-0412862C0403553
Diseasegranulins measurement

SFTPA2 SFTPA1

5.44e-0412862EFO_0008141
DiseaseHamman-Rich syndrome

SFTPA2 SFTPA1

7.47e-0414862C0085786
Diseasebacterial pneumonia (biomarker_via_orthology)

SFTPA2 SFTPA1

7.47e-0414862DOID:874 (biomarker_via_orthology)
DiseaseEndometrioma

NTRK3 LRRK2 RORB GREB1

1.28e-03161864C0269102
DiseaseEndometriosis

NTRK3 LRRK2 RORB GREB1

1.28e-03161864C0014175
DiseaseFamilial Idiopathic Pulmonary Fibrosis

SFTPA2 SFTPA1

1.54e-0320862C4721952
Diseasecup-to-disc ratio measurement

NEDD9 RAPGEF3 GLI3 ACTN4 CCDC171 ELFN2

1.63e-03430866EFO_0006939
DiseaseIdiopathic Pulmonary Fibrosis

SFTPA2 SFTPA1

1.70e-0321862C1800706
Diseasesevere acute respiratory syndrome, COVID-19

ARHGEF28 USP9X APOL4 SLFN5 ZFPM2 KLHL4

1.98e-03447866EFO_0000694, MONDO_0100096
DiseaseOvarian Serous Adenocarcinoma

TRPM7 LRRK2

2.04e-0323862C1335177
Diseasecongenital diaphragmatic hernia (biomarker_via_orthology)

SFTPA2 SFTPA1

2.22e-0324862DOID:3827 (biomarker_via_orthology)

Protein segments in the cluster

PeptideGeneStartEntry
QDLQHLDNEESDHHQ

ASGR1

6

P07306
LTHQQQLEEQDHLLE

AKAP9

271

Q99996
SNTEFLQVIEIHNHQ

ABRAXAS2

46

Q15018
EVQNVDDQHLLLHDQ

TFAP2C

176

Q92754
LEHHQLSQFQLLEQE

NEDD9

661

Q14511
NLNNRLQHDVAHLFI

ADAM20

286

O43506
AQELEENLNELTHIH

APOL4

331

Q9BPW4
LNHIEKSHEQLVLEN

CCDC171

696

Q6TFL3
HIHNNSENIVNELFI

ADGRF4

226

Q8IZF3
HQLIQEALIFDNKHT

ACTN4

711

O43707
LEHEQEKTHLLQQHN

CEP112

666

Q8N8E3
HTRLQNEHVKLQNEL

CEP83

56

Q9Y592
QLLEQHQVSDLTDFH

DNHD1

1586

Q96M86
LKNLEHHEVLVFQQT

ADCY10

741

Q96PN6
LEIKNNHLNQAIHEE

RALBP1

566

Q15311
NHLNQAIHEEREAII

RALBP1

571

Q15311
EHLEAASHQNQQLET

GOLGA6A

476

Q9NYA3
LEELHQHTEQLVQDQ

PUM2

906

Q8TB72
RILSLQNHHIIENNH

PARP9

536

Q8IXQ6
EKEVHDQLLQLHSIQ

GOPC

116

Q9HD26
DRQHEELANVHQLQH

ARHGEF28

1431

Q8N1W1
FDTQEQLVHHINNDH

GLI3

491

P10071
QHEQLSRQHEAQLHE

HDAC4

96

P56524
HVHNFIILNVDLTQN

GREB1

1716

Q4ZG55
QREAELLTNLQHEHI

NTRK3

586

Q16288
HLQELNLNDNHLESF

LRR1

201

Q96L50
VDLHEQQLSLNQHNR

NADK2

236

Q4G0N4
EAQLEHAELQEQLHR

FYCO1

886

Q9BQS8
NDEIQNFIDTLHHTL

FSD1L

51

Q9BXM9
GFQTQRELLQHQELH

ZFPM2

371

Q8WW38
NVDQSLIHEAEHDNL

DDX60

1196

Q8IY21
ALILHLQHNTNIDVQ

DDX60L

106

Q5H9U9
LEEENHHLLSQIQLL

CCDC88C

1331

Q9P219
LNELHLDHNKIQAIE

BGN

231

P21810
QLQLDENELPHAVHF

LRRK2

1561

Q5S007
NVQVDHLNLLKQFEH

NUCB1

126

Q02818
LQQHNLIVHFQANED

KLHL4

91

Q9C0H6
LEELHQHTEQLVQDQ

PUM1

1026

Q14671
QQHKNLLSEHEQLVV

GOLIM4

201

O00461
QAFVEELQFLQSHHL

OBSCN

5706

Q5VST9
LHQQESQSLQLHFRV

ITGA5

926

P08648
EQHGLQLQSEINQLH

EEA1

406

Q15075
ENLHDQVQEQKAHLR

EEA1

596

Q15075
QQHQADLELIESAHR

FBF1

616

Q8TES7
NVQEDDLQHLQLFTE

ATL1

181

Q8WXF7
HLQLSHQKLSQLQEE

CCDC141

326

Q6ZP82
QNEKTQLQAHLDHLI

CCDC150

411

Q8NCX0
QLQAHLDHLILEHNQ

CCDC150

416

Q8NCX0
RELEQQLHAQAAEHL

CRACR2B

261

Q8N4Y2
QLHAQAAEHLEAQAQ

CRACR2B

266

Q8N4Y2
SQNIQEDDLQHLQLF

ATL2

206

Q8NHH9
QLEQLLEENHEIISH

MAN2A2

56

P49641
HVELIQNVLQSDHFL

IQCB1

156

Q15051
QNVLQSDHFLHLLQA

IQCB1

161

Q15051
SDHFLHLLQADNVQI

IQCB1

166

Q15051
LQNTVDILLHHIFQE

SACS

3621

Q9NZJ4
DEEVREFLHNNLHLQ

RYR1

3546

P21817
LQVAQQENHHLNLDL

CALCOCO1

286

Q9P1Z2
LFLEHAHNLADNVQS

CEBPG

121

P53567
QEQHSQELLAELLTH

TBRG4

196

Q969Z0
QHVQLLFDNEVLPDH

PCGF1

216

Q9BSM1
NLSHDLVQEAIDHAQ

LAMA4

581

Q16363
HQQILHLVNVSNEDT

CFAP221

76

Q4G0U5
DLINQLQHNHALVTL

USP9X

601

Q93008
EHLQANQHLANIVER

TRIM34

66

Q9BYJ4
HIFRDEINLHQLNDE

PRUNE2

86

Q8WUY3
QLHINHNSLEILKED

SLITRK6

116

Q9H5Y7
ENLFEAQQLLLHHQQ

SYNE1

1266

Q8NF91
FNQLEDELNSHEHEL

SYNE1

2021

Q8NF91
HKEDLEQHSRQLQEQ

TMEM191B

136

P0C7N4
NSNENIIFVHNTIHL

NBEA

1371

Q8NFP9
HLLNSEHLATQAEQQ

PHF12

416

Q96QT6
VNAVALQDHILHDLQ

RNF32

16

Q9H0A6
AFLHQRQEILQHVDV

ST8SIA3

96

O43173
LEEQARHLLNEQEHA

WHRN

426

Q9P202
ELQATLHDFRHQILQ

SFTPA2

106

Q8IWL1
ELQATLHDFRHQILQ

SFTPA1

106

Q8IWL2
EHTHLLQSNQQLREI

CEP164

986

Q9UPV0
HEGNHTLVENLINFE

RAPGEF3

826

O95398
LLHHQKIQTLDQNVE

ZNF157

121

P51786
TLQHEKIQTLDHNFE

ZNF33B

206

Q06732
NHEELSARQHIADQL

UNC80

2866

Q8N2C7
ESLQHESDLLQHDQI

ZNF260

6

Q3ZCT1
QEEFQHLKTQAEQLH

TAFAZZIN

241

Q16635
LQHHITEQLQDIVDI

PPM1H

166

Q9ULR3
EHINIHKLRENVFQE

CTTN

51

Q14247
FALQHVIQKNHLDDE

RORB

401

Q92753
LLEIDHRQQQQHTND

WDR62

756

O43379
LKQNRSQEIDDHQHE

TRIP11

221

Q15643
QHESAQLQEELHQLQ

TRIP11

1236

Q15643
ENLNLENHRDQELLH

ZNF18

296

P17022
IQAQLEQHDIHNAKL

TXLNG

251

Q9NUQ3
EQHDIHNAKLRQENI

TXLNG

256

Q9NUQ3
EHIQHIIIDDAQNFR

SLFN5

641

Q08AF3
NVLNNLHSHFILVDD

TRPM7

236

Q96QT4
NVLFHSLLNLAQEDH

TEX38

181

Q6PEX7
QEAEQLQREHEQFQH

TRIO

941

O75962
QHINSTVHDLRLNEN

ELFN2

51

Q5R3F8
QERQHLQDLLHQEVL

MYO9A

1006

B2RTY4